High Systemic Immune-Inflammation Index Values Before Treatment Predict Poor Pancreatic Cancer Outcomes After Definitive Chemoradiotherapy.

MLA

Topkan, Erkan, et al. “High Systemic Immune-Inflammation Index Values Before Treatment Predict Poor Pancreatic Cancer Outcomes After Definitive Chemoradiotherapy.” Clinical Medicine Insights: Oncology, Nov. 2024, pp. 1–8. EBSCOhost, https://doi.org/10.1177/11795549241298552.

APA

Topkan, E., Kucuk, A., Ozturk, D., Ozkan, E. E., Kılıç Durankuş, N., Şenyürek, Ş., Selek, U., & Pehlivan, B. (2024). High Systemic Immune-Inflammation Index Values Before Treatment Predict Poor Pancreatic Cancer Outcomes After Definitive Chemoradiotherapy. Clinical Medicine Insights: Oncology, 1–8. https://doi.org/10.1177/11795549241298552

Chicago

Topkan, Erkan, Ahmet Kucuk, Duriye Ozturk, Emine Elif Ozkan, Nilüfer Kılıç Durankuş, Şükran Şenyürek, Ugur Selek, and Berrin Pehlivan. 2024. “High Systemic Immune-Inflammation Index Values Before Treatment Predict Poor Pancreatic Cancer Outcomes After Definitive Chemoradiotherapy.” Clinical Medicine Insights: Oncology, November, 1–8. doi:10.1177/11795549241298552.